Racura Oncology Secures Ethics Committee Approval for Lung Cancer Clinical Trial for Trial Sites Outside Victoria
() -- Racura Oncology (ASX:RAC) said the Bellberry human research ethics committee approved the HARNESS-1 lung cancer clinical trial, for Australian private hospital sites and eligible public hospital sites outside Victoria, allowing for additional clinical trial sites to be activated, according to a Friday Australian